- Volume 17 Issue 8
DOI QR Code
Global Prostate Cancer Incidence and Mortality Rates According to the Human Development Index
- Khazaei, Salman (Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences) ;
- Rezaeian, Shahab (Social Development & Health Promotion Research Center, Gonabad University of Medical Sciences) ;
- Ayubi, Erfan (Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences) ;
- Gholamaliee, Behzad (Social Determinants in Health Promotion Research Center, Hormozgan University of Medical Sciences) ;
- Pishkuhi, Mahin Ahmadi (School of Public Health, Alborz University of Medical Sciences) ;
- Khazaei, Somayeh (BSc in Operating Room, Rafsanjan University of Medical Sciences) ;
- Mansori, Kamyar (Social Determinants of Health Research Center, Kurdistan University of Medical Sciences) ;
- Nematollahi, Shahrzad (Department of Epidemiology, School of Public Health, Tehran University of Medical Sciences) ;
- Sani, Mohadeseh (School of Medicine, Zabol University of Medical Sciences) ;
- Hanis, Shiva Mansouri (Students' Research Committee (SRC), Baqiyatallah University of Medical Sciences)
- Published : 2016.08.01
Background: Prostate cancer (PC) is one of the leading causes of death, especially in developed countries. The human development index (HDI) and its dimensions seem correlated with incidence and mortality rates of PC. This study aimed to assess the association of the specific components of HDI (life expectancy at birth, education, gross national income per 1000 capita, health, and living standards) with burden indicators of PC worldwide. Materials and Methods: Information of the incidence and mortality rates of PC was obtained from the GLOBOCAN cancer project in year 2012 and data about the HDI 2013 were obtained from the World Bank database. The correlation between incidence, mortality rates, and the HDI parameters were assessed using STATA software. Results: A significant inequality of PC incidence rates was observed according to concentration indexes=0.25 with 95% CI (0.22, 0.34) and a negative mortality concentration index of -0.04 with 95% CI (-0.09, 0.01) was observed. Conclusions: A positive significant correlation was detected between the incidence rates of PC and the HDI and its dimensions including life expectancy at birth, education, income, urbanization level and obesity. However, there was a negative significant correlation between the standardized mortality rates and the life expectancy, income and HDI.
Human development index;prostate cancer;correlation;GLOBOCAN cancer project
- Baade PD, Youlden DR, Cramb SM, et al (2013). Epidemiology of prostate cancer in the Asia-Pacific region. Prostate Int, 1, 47-58. https://doi.org/10.12954/PI.12014
- Bloodgood JC (2016). Cancer of the Breast: Figures Which Show That Education Can Increase the Number of Cures. JAMA, 315, 709. https://doi.org/10.1001/jama.2015.17074
- Brawley OW (2012). Prostate cancer epidemiology in the United States. World J Urol, 30, 195-200. https://doi.org/10.1007/s00345-012-0824-2
- Bray F, Jemal A, Grey N, et al (2012). Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol, 13, 790-801. https://doi.org/10.1016/S1470-2045(12)70211-5
- Center MM, Jemal A, Lortet-Tieulent J, et al (2012). International variation in prostate cancer incidence and mortality rates. Eur Urol, 61, 1079-92. https://doi.org/10.1016/j.eururo.2012.02.054
- Cullen J, Elsamanoudi S, Brassell SA, et al (2012). The burden of prostate cancer in Asian nations. J Carcinogenesis, 11, 7. https://doi.org/10.4103/1477-3163.94025
- Decker KM, Demers AA, Nugent Z, et al (2016). Reducing income-related inequities in colorectal cancer screening: lessons learned from a retrospective analysis of organised programme and non-programme screening delivery in Winnipeg, Manitoba. BMJ Open, 6, 9470.
- Ekeke O, Amusan O, Eke N (2012). Management of prostate cancer in Port Harcourt, Nigeria: Changing patterns. J West African College Surg, 2, 58.
- Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
- Hassona Y, Sawair F, Baqain Z, et al (2015). Oral cancer early detection-a pressing need for continuing education in Jordan. Asian Pac J Cancer Prev, 16, 7727. https://doi.org/10.7314/APJCP.2015.16.17.7727
- Hebert JR, Ghumare SS, Gupta PC (2006). Stage at diagnosis and relative differences in breast and prostate cancer incidence in India: comparison with the United States. Asian Pacific J Cancer Prev, 7, 547.
- International Agency for Research on Cancer (2012). Prostate cancer estimated incidence, mortality and prevalence worldwide in 2012. Retrieved September, 6, 2014.
- Jemal A, Bray F, Forman D, et al (2012). Cancer burden in Africa and opportunities for prevention. Cancer, 118, 4372-84. https://doi.org/10.1002/cncr.27410
- Malik K (2013). Human development report 2013. United Nations Development Programme, New York.
- Moller E, Adami HO, Mucci LA, et al (2013). Lifetime body size and prostate cancer risk in a population-based case-control study in Sweden. Cancer Causes Control, 24, 2143-55. https://doi.org/10.1007/s10552-013-0291-0
- Morris LG, Sikora AG, Tosteson TD, et al (2013). The increasing incidence of thyroid cancer: the influence of access to care. Thyroid, 23, 885-91. https://doi.org/10.1089/thy.2013.0045
- Orsted DD, Bojesen SE (2013). The link between benign prostatic hyperplasia and prostate cancer. Nature Reviews Urol, 10, 49-54. https://doi.org/10.1038/nrurol.2012.192
- Pakzad R, Mohammadian-Hafshejani A, Ghoncheh M, et al (2015). The incidence and mortality of prostate cancer and its relationship with development in Asia. Prostate Int, 3, 135-40. https://doi.org/10.1016/j.prnil.2015.09.001
- Plata BA, Concepcion MT (2014). Prostate cancer epidemiology. Archivos Espanoles De Urologia, 67, 373-82.
- Salomon JA, Wang H, Freeman MK, et al (2013). Healthy life expectancy for 187 countries, 1990–2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet, 380, 2144-62.